We deliver end-to-end Glycan-Specific Diagnostics services that combine advanced glycomics expertise with state-of-the-art analytical technologies. Using high-resolution mass spectrometry, liquid chromatography, and proprietary bioinformatics pipelines, we reveal subtle changes in glycosylation that traditional assays often miss. Whether you are a pharmaceutical company ensuring the quality of therapeutic antibodies, a research team exploring new glycan biomarkers for cancer or autoimmune diseases, or a healthcare innovator seeking early-detection solutions, our tailored workflows provide reliable, reproducible, and publication-ready results. By transforming complex glycan data into actionable insights, we empower you to accelerate discovery and maintain regulatory compliance-all from a single trusted partner.
Early Disease Detection: Subtle glycan alterations can signal cancer, autoimmune disorders, or infectious diseases before conventional biomarkers.
Therapeutic Monitoring: Track how treatment affects glycan profiles in real time, improving personalized medicine strategies.
Biopharmaceutical Quality Control: Ensure consistency and regulatory compliance of therapeutic antibodies, vaccines, and biologics by monitoring glycosylation patterns.
Complexity Simplified: Glycan structures are notoriously difficult to analyze; we provide streamlined, high-accuracy workflows that deliver clear and reproducible results.
Data Bottlenecks: We eliminate the challenge of interpreting complex spectra by using state-of-the-art glycan databases and AI-driven analysis tools.
We provide in-depth analysis of both N- and O-linked glycans across diverse biological samples.
Our platform delivers accurate quantification to reveal meaningful biological differences.
We pinpoint exact glycosylation sites to uncover their biological impact.
We target disease-related modifications that play critical roles in oncology and immunology.
We design tailored projects to identify novel glycan-based disease markers.
We support biopharma manufacturers with validated methods for compliance.
We transform complex glycomics data into actionable insights.
Choosing our Glycan-Specific Diagnostics services means partnering with a trusted expert team focused on quality, innovation, and client success.
End-to-End Expertise: From sample preparation to data interpretation, we handle the entire workflow in-house.
High Sensitivity & Accuracy: Advanced instruments and validated methods deliver reliable, reproducible results.
Customizable Solutions: Flexible workflows designed for biopharma or academic discovery.
Fast Turnaround Time: Optimized processes ensure rapid project completion without sacrificing quality.
Actionable Insights: Reports tailored to support decision-making in biomarker research or drug development.
Global Client Support: Dedicated project managers and technical experts available for consultation worldwide.
We follow a transparent, step-by-step process to ensure accuracy, reproducibility, and customer satisfaction.
Understand your research objectives.
Define sample requirements, scope, and expected outcomes.
Tailor workflows to meet regulatory and scientific standards.
Controlled extraction of N- and O-glycans from your samples.
Enzymatic and chemical workflows optimized for high yield.
Quality checks to minimize variability and maximize reproducibility.
High-resolution LC-MS/MS and chromatography-based characterization.
Site-specific glycoproteomics and targeted glycan modification detection.
Quantitative profiling for biomarker discovery and product quality control.
AI-driven spectral analysis with curated glycan databases.
Structural annotation, quantification, and statistical validation.
Integration with proteomic or genomic data for deeper insights.
Clear, publication-ready reports with full structural annotations.
Visual data presentation for easy interpretation.
Optional follow-up consultation to discuss applications and next steps.
We work with serum, plasma, tissue extracts, urine, saliva, and purified therapeutic proteins, depending on your project needs.
Our high-resolution LC-MS/MS workflows provide unparalleled sensitivity and specificity, detecting subtle glycan changes often missed by conventional methods.
Absolutely. We deliver comprehensive data interpretation, statistical validation, and publication-ready reports with visualizations.
Yes. From biomarker discovery to QC solutions, we design tailored workflows that meet the specific needs of your research or product development.
Partner with us to transform complex glycosylation data into actionable insights for biomarker discovery, drug development, and diagnostics. Our team not only delivers high-resolution analysis but also provides relevant glycans such as sialylated N-glycans, fucosylated structures, high-mannose glycans, hybrid-type glycans, and O-glycans associated with disease progression. Whether you're in oncology research, autoimmune disease monitoring, or biopharmaceutical development, we have the tools and expertise to accelerate your success.
Contact us today to discuss your project, request a free consultation, or receive a customized quote for your glycan analysis needs.
